Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Back to institutions

Skin Health Institute

Carlton, Victorianonprofit

545

Works

10,706

Citations

48

h-index

Top Research Topics

Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Contact Dermatitis and Allergies

Top Researchers

Vincent Thijs The University of Melbourne

688 works42,059 citationsh-index: 95

Recent Research

Grading of Erythema and Visual Attributes in Atopic Dermatitis across Diverse Skin Tones Using a Vision AI Pipeline

Mahla Abdolahnejad,Manuella Kyremeh,et al.

20260 citations

Skin Health Institute | Researchclopedia

Autoimmune Bullous Skin Diseases

Dermatologic Treatments and Research

Nail Diseases and Treatments

Cutaneous Melanoma Detection and Management

Acne and Rosacea Treatments and Effects

Skin Protection and Aging

Hair Growth and Disorders

Pesticide Exposure and Toxicity

melanin and skin pigmentation

Adam Witkowski Institute of Cardiology

563 works35,274 citationsh-index: 47

Yoshiki Miyachi Shizuoka University

925 works25,854 citationsh-index: 78

Chris I. Baker National Institutes of Health

333 works20,470 citationsh-index: 68

Cindy Kok Sydney Hospital

62 works13,665 citationsh-index: 20

Nigam P. Rath University of Missouri–St. Louis

1,104 works13,232 citationsh-index: 53

Expert Consensus on the Rational Approach to Isotretinoin Usage for Effective Management of Acne: ERAISE ACNE Recommendations

Sanjiv Kandhari,Jayakar Thomas,et al.

20260 citations

Presumed Pustular Allergic Contact Dermatitis From Airborne Epoxy Resin Exposure

Thomas R. Brasher,Jennifer Cahill,et al.

20260 citations

Challenging interpretation of low-level PTCH1 mosaicism in patients with clinically diagnosed Gorlin syndrome: a case series and review of the literature

Tanya M. Dwarte,Rozanna Alli,et al.

20260 citations

Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients with alopecia areata: efficacy and safety results of a phase II, multicenter, randomized, double-blinded, placebo-controlled trial

Brett King,B. Ehst,et al.

20260 citations

The Utility of Artificial Intelligence in Dermatology Training and Practice: A National, Cross‐Sectional Study

Samuel Morriss,Andrew Awad,et al.

20260 citations